Two Sigma Securities’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
HWA
DB
Two Sigma Securities's CODX Position: Q1 2026 in Review
Two Sigma Securities sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 1,026 shares — an estimated $5.19K sold.
Two Sigma Securities first reported a position in CODX in Q4 2017 and held it in 8 quarters. The position peaked at $49K in Q3 2022. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- Two Sigma Securities reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 1,026 Co-Diagnostics shares in Q1 2026, an estimated $5.19K.
- Two Sigma Securities first reported a position in Co-Diagnostics in Q4 2017 and held it in 8 quarters.
- Two Sigma Securities's Co-Diagnostics position peaked at $49K in Q3 2022.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.